Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment

PURPOSE: To evaluate adverse drug reactions (ADRs) experienced by chronic myeloid leukemia (CML) patients during per oral tyrosine kinase inhibitor (TKI) treatment and correlation of ADR symptoms with medication adherence and perceived quality of life (QoL). PATIENTS AND METHODS: Eighty-six adult, c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Patient Prefer Adherence
Autors principals: Kekäle, Meri, Peltoniemi, Marikki, Airaksinen, Marja
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4677761/
https://ncbi.nlm.nih.gov/pubmed/26677317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S92125
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars